BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17855650)

  • 1. Serpin peptidase inhibitor clade A member 1 as a potential marker for malignancy in insulinomas.
    de Sá SV; Corrêa-Giannella ML; Machado MC; Krogh K; de Almeida MQ; Albergaria Pereira MA; Coelho Siqueira SA; Patzina RA; Ibuki FS; Sogayar MC; Machado MC; Giannella-Neto D
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5322-30. PubMed ID: 17855650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced TGF-beta1 expression and its target genes in human insulinomas.
    Nabokikh A; Ilhan A; Bilban M; Gartner W; Vila G; Niederle B; Nielsen JH; Wagner O; Base W; Luger A; Wagner L
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):674-82. PubMed ID: 18058603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.
    Waldmann J; Fendrich V; Holler J; Buchholz M; Heinmöller E; Langer P; Ramaswamy A; Samans B; Walz MK; Rothmund M; Bartsch DK; Slater EP
    Endocr Relat Cancer; 2010 Sep; 17(3):743-56. PubMed ID: 20562231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal instability predicts metastatic disease in patients with insulinomas.
    Jonkers YM; Claessen SM; Perren A; Schmid S; Komminoth P; Verhofstad AA; Hofland LJ; de Krijger RR; Slootweg PJ; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2005 Jun; 12(2):435-47. PubMed ID: 15947114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.
    Jonkers YM; Claessen SM; Veltman JA; Geurts van Kessel A; Dinjens WN; Skogseid B; Ramaekers FC; Speel EJ
    Cytogenet Genome Res; 2006; 115(3-4):289-97. PubMed ID: 17124412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
    Davidson ME; Kerepesi LA; Soto A; Chan VT
    Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays.
    Ma LJ; Li W; Zhang X; Huang DH; Zhang H; Xiao JY; Tian YQ
    Arch Med Res; 2009 Feb; 40(2):114-23. PubMed ID: 19237021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
    Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
    J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
    Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
    Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stathmin as a marker for malignancy in pheochromocytomas.
    Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
    Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
    Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.